e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Improvements in delivery of inhaled agents
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol
S. Verbanck, D. Schuermans, M. Paiva, W. Vincken (Brussels, Belgium)
Source:
Annual Congress 2004 - Improvements in delivery of inhaled agents
Session:
Improvements in delivery of inhaled agents
Session type:
Thematic Poster Session
Number:
3571
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Verbanck, D. Schuermans, M. Paiva, W. Vincken (Brussels, Belgium). Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol. Eur Respir J 2004; 24: Suppl. 48, 3571
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation
Source: Eur Respir J 2005; 26: Suppl. 49, 503s
Year: 2005
Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment
Source: Eur Respir J 2008; 31: 1145-1147
Year: 2008
Diverging airway inflammatory responses to diesel exhaust exposure in healthy and asthmatic subjects with and without inhaled corticosteroid treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 22s
Year: 2002
Increased asthma medication use in association with ambient fine and ultrafine particles
Source: Eur Respir J 2002; 20: 691-702
Year: 2002
The effects of inhaled acid aerosol on lung function of asthmatic children
Source: Eur Respir J 2003; 22: Suppl. 45, 497s
Year: 2003
Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 670s
Year: 2006
Airway inflammation and inhaled corticosteroids in COPD
Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017
Year: 2017
Inhaled corticosteroids and growth of airway function in asthmatic children
Source: Eur Respir J 2004; 23: 861-868
Year: 2004
Effect of montelukast added to inhaled steroids on exhaled NO in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 40s
Year: 2001
Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Effect of formoterol with or without budesonide in repeated low-dose allergen challenge
Source: Eur Respir J 2009; 33: 747-753
Year: 2009
Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
High doses inhaled salbutamol by MDI in patients with acute bronchial asthma and its cardiopulmonary effects
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009
The effect of inhaled corticosteroids on airway hyperresponsiveness to mannitol in patients with Type 2 low asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Effect of add-on montelukast to inhaled corticosteroids on excessive airway narrowing in adult asthmatics
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009
Refractory asthmatics showing no bronchial reversibility with high-dose inhaled corticosteroids or β
2
agonist inhalation: is this phenomenon airway remodeling?
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Effect of inhaled salmeterol or fluticasone on organic dust induced bronchial hyperreactivity
Source: Eur Respir J 2002; 20: Suppl. 38, 308s
Year: 2002
Mycobiota of the pharynx in patients with persistent bronchial asthma who constantly applying the inhaled corticosteroids
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012
Assessing regional airways responses to inhaled bronchodilators in asthmatics
Source: Annual Congress 2010 - Airways mechanics in different applications
Year: 2010
Assessing small airways dysfunction in asthma, asthma remission and healthy controls using particles in exhaled air
Source: ERJ Open Res, 5 (4) 00202-2019; 10.1183/23120541.00202-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept